Improving the solubility of fraxinellone to increase its oral bioavailability and hepatoprotective action against acute liver injury in mice

Yaoxue Xuebao

Volumn 42, Issue 6, 2007, Pages 675-680

  Ran, Qi qiong ^a   Ruan, Li ping ^a   Zhu, Dan ni ^a   Yu, Bo yang ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Bioavailability; Fraxinellone; HP CD; In vivo activity; Solubility

Indexed keywords

BENZOFURAN DERIVATIVE; CARBON TETRACHLORIDE; FRAXINELLONE;

ANIMAL; ARTICLE; BIOAVAILABILITY; CHEMISTRY; DRUG EFFECT; FEMALE; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER; MALE; MOUSE; PH; RAT; SOLUBILITY; SPRAGUE DAWLEY RAT;

ANIMALS; BENZOFURANS; BIOLOGICAL AVAILABILITY; CARBON TETRACHLORIDE; FEMALE; HYDROGEN-ION CONCENTRATION; LIVER; MALE; MICE; MICE, INBRED ICR; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 34547479391     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Amidon GL, Lennernas H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability [J]. Pharm Res, 1995,12:413-420.
2. Zhang YS, Ning ZX, Yang SZ, et al. Antioxidation properties and mechanism of action of dihydromyricetin from Ampelopsis grossedentata [J]. Acta Pharm Sin, 2003,38:241-244.
3. Zhang YS, Ning ZX, Hu YY. Research on flavonol of dihydromyricetin [J]. Chin Tradit Pat Med, 2002,24:970-972.
4. Ruan LP, Yu BY, Zhu DL, et al. Studies on correlation between intestine absorption and in vivo activity of Genistein [J]. Chin J Nat Med, 2006,4:278-282.
5. Rang SL, Wang SX, Zhu TR. Study on active constituents of Dictamnus dasycarpus Turcz [J]. J Shenyang Pharm Univ, 1984,18: 11-15.
6. Wu TS, Wang ML, Shyur HJ, et al. Chemical constituents and bioactive principles from the root bark of Dictamnus dasycarpus [J] Chin Pharm J (Taipei), 1994, 46:447-455.
7. 2+ channel blockers [J]. Naunyn-Schmiedeberg's Arch of Pharm (Histor Arch), 1992,345:349-355.
8. Liu ZL, Xu YJ, Wu J, et al. Feeding deterrents from Dictamnus dasycarpus Turcz against two stored-product insects [J]. J Agric Food Chem, 2002,50:1447-1450.
9. Xu Q, Wu FH, Zhu DN, et al. The potential application of fraxinellone in liver disease treatment: CN, 1724527 A [P]. 2006-01-25.
10. Ruan LP, Chen S, Yu BY, et al. Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model [J]. Euro J Med Chem, 2006,41: 605-610.
11. Zhang YJ, Zhang Q, Hou JL, et al. The pharmacokinetics and pharmacodynamics of recombinant hirudin-2 nasal spray [J]. Acta Pharm Sin, 2006,41:268-271.
12. Li HY, Zhang FR, Wu LJ, et al. Pharmacokinetics of artenibenzoate in rats [J]. Acta Pharm Sin, 1995,30:422-427.
13. Yang G, Jain N, Yalkowsky SH. Combined effect of SLS and (SBE) (7M)-β-CD on the solubilization of NSC-639829 [J]. Int J Pharm, 2004,269:141-148.
14. Wong CK, Ooi VEC, Ang PO. Protective effects of seaweeds against liver injury caused by carbon tetrachloride in rats [J]. Chemosphere, 2000,41:173-176.